Immunity and hepatitis C

A review

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatocellular carcinoma worldwide. Due to shared transmission routes, the prevalence of HCV is especially high among individuals infected with HIV. HIV uninfected individuals spontaneously clear HCV approximately 30 % of the time, while the rate of control in HIV infected individuals who subsequently acquire HCV is substantially lower. In addition, complications of HCV are more frequent in those with HIV infection, making liver disease the leading cause of non-AIDS-related death in HIV infected individuals. This review summarizes recent advances in understanding the role of the innate and adaptive immune responses to HCV in those with and without HIV. Further defining the interaction between hepatitis C and the host immune system will potentially reveal insights into HCV pathogenesis and the host's ability to prevent persistent infection, as well as direct the development of vaccines.

Original languageEnglish (US)
Pages (from-to)51-58
Number of pages8
JournalCurrent HIV/AIDS Reports
Volume10
Issue number1
DOIs
StatePublished - Mar 2013

Fingerprint

Hepatitis C
Hepacivirus
Immunity
HIV
Adaptive Immunity
Chronic Hepatitis
Innate Immunity
HIV Infections
Liver Diseases
Hepatocellular Carcinoma
Immune System
Vaccines
Infection

Keywords

  • Acute infection
  • Adaptive immune response
  • B cell response
  • Cellular immunity
  • Chronic infection
  • Coinfection
  • HCV
  • Hepatitis
  • Hepatitis C
  • HIV
  • HIV-HCV coinfection
  • IFN
  • Immunity
  • Innate immune response
  • Interferons
  • Interleukin 18
  • Interleukin 28B
  • Liver disease
  • Neutralizing antibodies
  • Spontaneous clearance
  • SVR
  • T cell response
  • Treatment response
  • Vaccination
  • Viral hepatitis
  • Virus

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Immunity and hepatitis C : A review. / Terilli Veenhuis, Rebecca; Cox, Andrea.

In: Current HIV/AIDS Reports, Vol. 10, No. 1, 03.2013, p. 51-58.

Research output: Contribution to journalArticle

@article{d2b553dee4684df8baa970a370f7e7cd,
title = "Immunity and hepatitis C: A review",
abstract = "Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatocellular carcinoma worldwide. Due to shared transmission routes, the prevalence of HCV is especially high among individuals infected with HIV. HIV uninfected individuals spontaneously clear HCV approximately 30 {\%} of the time, while the rate of control in HIV infected individuals who subsequently acquire HCV is substantially lower. In addition, complications of HCV are more frequent in those with HIV infection, making liver disease the leading cause of non-AIDS-related death in HIV infected individuals. This review summarizes recent advances in understanding the role of the innate and adaptive immune responses to HCV in those with and without HIV. Further defining the interaction between hepatitis C and the host immune system will potentially reveal insights into HCV pathogenesis and the host's ability to prevent persistent infection, as well as direct the development of vaccines.",
keywords = "Acute infection, Adaptive immune response, B cell response, Cellular immunity, Chronic infection, Coinfection, HCV, Hepatitis, Hepatitis C, HIV, HIV-HCV coinfection, IFN, Immunity, Innate immune response, Interferons, Interleukin 18, Interleukin 28B, Liver disease, Neutralizing antibodies, Spontaneous clearance, SVR, T cell response, Treatment response, Vaccination, Viral hepatitis, Virus",
author = "{Terilli Veenhuis}, Rebecca and Andrea Cox",
year = "2013",
month = "3",
doi = "10.1007/s11904-012-0146-4",
language = "English (US)",
volume = "10",
pages = "51--58",
journal = "Nature Clinical Practice Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Immunity and hepatitis C

T2 - A review

AU - Terilli Veenhuis, Rebecca

AU - Cox, Andrea

PY - 2013/3

Y1 - 2013/3

N2 - Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatocellular carcinoma worldwide. Due to shared transmission routes, the prevalence of HCV is especially high among individuals infected with HIV. HIV uninfected individuals spontaneously clear HCV approximately 30 % of the time, while the rate of control in HIV infected individuals who subsequently acquire HCV is substantially lower. In addition, complications of HCV are more frequent in those with HIV infection, making liver disease the leading cause of non-AIDS-related death in HIV infected individuals. This review summarizes recent advances in understanding the role of the innate and adaptive immune responses to HCV in those with and without HIV. Further defining the interaction between hepatitis C and the host immune system will potentially reveal insights into HCV pathogenesis and the host's ability to prevent persistent infection, as well as direct the development of vaccines.

AB - Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatocellular carcinoma worldwide. Due to shared transmission routes, the prevalence of HCV is especially high among individuals infected with HIV. HIV uninfected individuals spontaneously clear HCV approximately 30 % of the time, while the rate of control in HIV infected individuals who subsequently acquire HCV is substantially lower. In addition, complications of HCV are more frequent in those with HIV infection, making liver disease the leading cause of non-AIDS-related death in HIV infected individuals. This review summarizes recent advances in understanding the role of the innate and adaptive immune responses to HCV in those with and without HIV. Further defining the interaction between hepatitis C and the host immune system will potentially reveal insights into HCV pathogenesis and the host's ability to prevent persistent infection, as well as direct the development of vaccines.

KW - Acute infection

KW - Adaptive immune response

KW - B cell response

KW - Cellular immunity

KW - Chronic infection

KW - Coinfection

KW - HCV

KW - Hepatitis

KW - Hepatitis C

KW - HIV

KW - HIV-HCV coinfection

KW - IFN

KW - Immunity

KW - Innate immune response

KW - Interferons

KW - Interleukin 18

KW - Interleukin 28B

KW - Liver disease

KW - Neutralizing antibodies

KW - Spontaneous clearance

KW - SVR

KW - T cell response

KW - Treatment response

KW - Vaccination

KW - Viral hepatitis

KW - Virus

UR - http://www.scopus.com/inward/record.url?scp=84873706272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873706272&partnerID=8YFLogxK

U2 - 10.1007/s11904-012-0146-4

DO - 10.1007/s11904-012-0146-4

M3 - Article

VL - 10

SP - 51

EP - 58

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

SN - 1759-4774

IS - 1

ER -